Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, August 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 2 X users

Readers on

mendeley: 47 Mendeley

Summary Policy documents X

So far, Altmetric has seen 1 policy document that references this research output.

Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes

Cited by Canadian Agency for Drugs and Technologies in Health on 16 Aug 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Dove Medical Press

Article Metrics